Pharmaceutical Market Europe • November 2020 • 3

COMMENT

Life in lockdown

As lockdown restrictions tighten, it is important to look after our mental and physical health while working from home. In Mike Dixon’s column this month he looks at the positive side of working from home and not having to be “either the person dressed like you’re in the Caribbean because you’re sitting under the heating vent or the person dressed like the Michelin man with the corner desk in the Arctic”! On the not so positive side, however, the dramatic changes to our routines during lockdown have resulted in us losing a lot of the well-being benefits our previous routines used to provide. Read Mike’s column on page 14 to find out more about why it’s important for us all to take a moment to think about how we can make the best of working from home, while also keeping an eye on the less positive aspects.

In our monthly cover article from Chris Ross, he looks at creativity and how the pandemic has shifted the dial and has thrust creativity into the spotlight and underlined its strategic importance.

Chris writes that “the pandemic has liberated a speed and agility in creative decision-making that’s brought about ‘five years of innovation in just five months’, and that pharma’s creative approach is beginning to attract attention from other industries, rather than the other way around”. He goes on to say that “creativity cannot exist in isolation – it requires collaboration, cross-pollination, diversity and difference. Most of all, it requires a deep understanding of customer behaviours”. Read more about the importance of creativity on page 30.

I hope you enjoy this issue!

Image

Iona Everson
Group Managing Editor

Keep up to date with the latest developments in the UK and global healthcare marketplace – sign up to daily or weekly news alerts and fortnightly or monthly bulletins on specific topics at  www.pmlive.com/register

Image

THE TEAM
Editorial:
Group Managing Editor
Iona Everson
Reporter
Lucy Parsons

Studio:
Executive Director
Karl Equi
Middleweight Graphic Designer
Helen Penfold

Sales:
Business Director
Tara Lovegrove

EDITORIAL ADVISORY BOARD
Philip Atkinson
Founder of Hive-Logic, Lifescience Transformation
Uday Bose
Corporate vice president, head of global marketing oncology, Boehringer Ingelheim
Dr Luc Hermans
VP commercial planning and operations Europe, Asia, Middle East, Gilead Sciences
Stefan Janssens
President EMEA, Cegedim Dendrite
John Morris
Partner, KPMG
Paul Pay
Chief business development officer, Norgine
Mark Rothera
Chief executive officer, Orchard Therapeutics
Ian Talmage
Senior vice president, global marketing, general medicine, Bayer Pharmaceuticals

PUBLISHED BY
PMGroup
Mansard House, Church Road, Little Bookham, Surrey, KT23 3JG, UK
Tel: +44 (0)1372 414200
Fax: +44 (0)1372 414201

CONTACT US
General enquiries: info@pmlive.com
Editorial: editor@pmlive.com
Advertising: sales@pmlive.com
Subscriptions: subscriptions@pmlive.com

Views expressed by the contributors do not necessarily represent those of the publisher, editor or staff.
© 2020 PMGroup
All rights reserved. No part of this publication may be copied, reproduced, transmitted, photocopied, recorded or stored on any retrieval system without the prior written consent of the publishers.
The magazine is also available at the following subscription rates: £120 UK, £180 Europe, £210 RoW

Image